RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Severity of Illness Index

This is a "connection" page, showing publications Luis M. Vilá has written about Severity of Illness Index.
Connection Strength

1.807
  1. Burgos PI, Alarc?n GS, McGwin G, Crews KQ, Reveille JD, Vil? LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009 Sep 15; 61(9):1179-86.
    View in: PubMed
    Score: 0.258
  2. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005 Nov; 32(11):2150-5.
    View in: PubMed
    Score: 0.198
  3. Gonz?lez-Mel?ndez A, B?ez-Negr?n L, R?os-Rivera R, Franco-O'Connell AS, Nieves-Plaza M, Vil? LM. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico. Lupus. 2023 Apr; 32(4):571-579.
    View in: PubMed
    Score: 0.163
  4. Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.
    View in: PubMed
    Score: 0.143
  5. Cintr?n D, Alanis JM, ?lvarez-Villalobos N, Rodr?guez-Guti?rrez R, Vil? LM. A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus. Lupus. 2020 Mar; 29(3):303-310.
    View in: PubMed
    Score: 0.133
  6. Villafr?dez-D?az M, Santiago-Casas Y, Nieves-Plaza M, Morales M, Rodr?guez V, R?os G, Mart?nez D, Vil? LM. Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. P R Health Sci J. 2014 Mar; 33(1):3-8.
    View in: PubMed
    Score: 0.088
  7. Jim?nez-Encarnaci?n E, Garc?a-Pallas MV, Vil? LM. Severe leg ulcers in a multiple myeloma patient with cryoglobulinemic vasculitis. P R Health Sci J. 2012 Jun; 31(2):71.
    View in: PubMed
    Score: 0.078
  8. Gonz?lez LA, Pons-Estel GJ, Zhang JS, McGwin G, Roseman J, Reveille JD, Vil? LM, Alarc?n GS. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus. 2009 Feb; 18(2):184-6.
    View in: PubMed
    Score: 0.062
  9. Sanchez ML, McGwin G, Dur?n S, Fern?ndez M, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1):67-71.
    View in: PubMed
    Score: 0.062
  10. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum. 2006 Oct 15; 55(5):799-806.
    View in: PubMed
    Score: 0.053
  11. Uribe AG, Vil? LM, McGwin G, Sanchez ML, Reveille JD, Alarc?n GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004 Oct; 31(10):1934-40.
    View in: PubMed
    Score: 0.046
  12. Mayor AM, Vil? LM. Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1339-44.
    View in: PubMed
    Score: 0.043
  13. Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.
    View in: PubMed
    Score: 0.042
  14. Ugarte-Gil MF, Dubey J, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus. Arthritis Care Res (Hoboken). 2023 03; 75(3):585-589.
    View in: PubMed
    Score: 0.040
  15. Ugarte-Gil MF, Pons-Estel GJ, Harvey GB, Vil? LM, Griffin R, Alarc?n GS. Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort. Arthritis Care Res (Hoboken). 2021 10; 73(10):1451-1455.
    View in: PubMed
    Score: 0.037
  16. Ugarte-Gil MF, Pons-Estel GJ, Griffin R, Vil? LM, Reveille JD, Alarc?n GS. Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort. Arthritis Care Res (Hoboken). 2021 07; 73(7):1038-1040.
    View in: PubMed
    Score: 0.036
  17. Alarc?n GS, Ugarte-Gil MF, Pons-Estel G, Vil? LM, Reveille JD, McGwin G. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort. Lupus. 2019 Mar; 28(3):423-426.
    View in: PubMed
    Score: 0.031
  18. Ugarte-Gil MF, Pimentel-Quiroz VR, Vil? LM, Reveille JD, McGwin G, Alarc?n GS. Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort. Lupus. 2017 May; 26(6):650-655.
    View in: PubMed
    Score: 0.026
  19. L?pez-L?pez L, Nieves-Plaza M, Castro Mdel R, Font YM, Torres-Ramos CA, Vil? LM, Ayala-Pe?a S. Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus. Lupus. 2014 Oct; 23(11):1133-41.
    View in: PubMed
    Score: 0.022
  20. Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012 Jul; 21(8):830-5.
    View in: PubMed
    Score: 0.019
  21. Burgos PI, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology (Oxford). 2010 Sep; 49(9):1720-5.
    View in: PubMed
    Score: 0.017
  22. Zhang J, Gonz?lez LA, Roseman JM, Vil? LM, Reveille JD, Al?rcon GS. Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus. 2010 May; 19(6):727-33.
    View in: PubMed
    Score: 0.017
  23. Pons-Estel BA, S?nchez-Guerrero J, Romero-D?az J, Iglesias-Gamarra A, Bonfa E, Borba EF, Shinjo SK, Bernatsky S, Clarke A, Garc?a MA, Marcos JC, Duarte A, Berbotto GA, Scherbarth H, Marques CD, Onetti L, Saurit V, Souza AW, Velozo E, Catoggio LJ, Neira O, Burgos PI, Ramirez LA, Molina JF, De La Torre IG, Silvari?o R, Manni JA, Dur?n-Barrag?n S, Vil? LM, Fortin PR, Calvo-Al?n J, Santos MJ, Portela M, Esteva-Spinetti MH, Weisman M, Acevedo EM, Segami MI, Gentiletti SB, Rold?n J, Navarro I, Gonzalez E, Liu JM, Karlson EW, Costenbader KH, Wolfe F, Alarc?n GS. Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus. 2009 Oct; 18(12):1033-52.
    View in: PubMed
    Score: 0.016
  24. Gonz?lez LA, Pons-Estel GJ, Zhang J, Vil? LM, Reveille JD, Alarc?n GS. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort. Lupus. 2009 Aug; 18(9):822-30.
    View in: PubMed
    Score: 0.016
  25. Bertoli AM, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 Dec; 35(12):2355-8.
    View in: PubMed
    Score: 0.015
  26. Dur?n-Barrag?n S, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford). 2008 Jul; 47(7):1093-6.
    View in: PubMed
    Score: 0.015
  27. Apte M, McGwin G, Vil? LM, Kaslow RA, Alarc?n GS, Reveille JD. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford). 2008 Mar; 47(3):362-7.
    View in: PubMed
    Score: 0.014
  28. Bertoli AM, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis. 2008 Apr; 67(4):500-4.
    View in: PubMed
    Score: 0.014
  29. Bertoli AM, Vil? LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. Rheumatology (Oxford). 2007 Sep; 46(9):1471-6.
    View in: PubMed
    Score: 0.014
  30. Chaiamnuay S, Bertoli AM, Fern?ndez M, Apte M, Vil? LM, Reveille JD, Alarc?n GS. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol. 2007 Jun; 13(3):128-33.
    View in: PubMed
    Score: 0.014
  31. Bastian HM, Alarc?n GS, Roseman JM, McGwin G, Vil? LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford). 2007 Apr; 46(4):683-9.
    View in: PubMed
    Score: 0.013
  32. Alarc?n GS, Calvo-Al?n J, McGwin G, Uribe AG, Toloza SM, Roseman JM, Fern?ndez M, Fessler BJ, Vil? LM, Ahn C, Tan FK, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006 Sep; 65(9):1168-74.
    View in: PubMed
    Score: 0.013
  33. Andrade RM, McGwin G, Alarc?n GS, Sanchez ML, Bertoli AM, Fern?ndez M, Fessler BJ, Apte M, Arango AM, Bastian HM, Vil? LM, Reveille JD. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology (Oxford). 2006 Nov; 45(11):1380-4.
    View in: PubMed
    Score: 0.013
  34. Bertoli AM, Alarc?n GS, McGwin G, Fern?ndez M, Bastian HM, Fessler BJ, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity. Lupus. 2006; 15(1):13-8.
    View in: PubMed
    Score: 0.012
  35. Ho KT, Ahn CW, Alarc?n GS, Baethge BA, Tan FK, Roseman J, Bastian HM, Fessler BJ, McGwin G, Vil? LM, Calvo-Al?n J, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford). 2005 Oct; 44(10):1303-7.
    View in: PubMed
    Score: 0.012
  36. Fern?ndez M, Calvo-Al?n J, Alarc?n GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G, Vil? LM, Sanchez ML, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005 Jun; 52(6):1655-64.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support